Lao People’s Democratic Republic (PDR) government is giving the highest priority to the healthcare sector, and this is making a great opportunity for foreign countries like Indian and China, taking various initiatives to promote the export of low-cost high-quality generics into Laos. Lao’s is a small country with a very small market for the medical, […]
Read More →There is a growing demand for generic drugs in Malaysia. The government is the largest pharmaceutical buyer in Malaysia and is responsible for more than half of the purchasing value. The Indian, Chinese, and other similar drug manufacturers have begun playing a dominant role in the Malaysian pharmaceutical market. In Malaysia, the pharmaceutical manufacturing sector […]
Read More →Indonesia’s pharmaceutical market is the largest market in the Association of Southeast Nations (ASEAN). The current pharmaceutical market is worth IDR 84 trillion (USD 6 billion) and is expected to reach $10.11 billion by 2021. Some interesting facts about Indonesia The Indonesian Pharmacists Association reported that about 95 percent of raw material for medicine is […]
Read More →The Asia-Pacific region is emerging as a new destination for generic drugs. The Asia-pacific market is forecasted to grow from USD 75 billion in 2020 to USD 112 billion by 2025 at a CAGR of 8.34%. The growth of the generic drugs market is accelerated by many factors such as the aging population, increasing pharmaceutical […]
Read More →The demand for healthcare products and services has been growing in ASEAN countries. Governments start facing the same problem as in more developed countries and struggle to finance the growing healthcare expenses. There is a steep increase in chronic diseases along with infectious diseases. This is creating an opportunity for the generic drug manufacturers to […]
Read More →Singapore is becoming a global center for the pharmaceutical industry due to the cost-effective and reliable medical services, high-quality pharmaceutical manufacturing and research, access to regional markets, and a skilled workforce. Also, the Government has supported several schemes to drive innovation and development. Singapore’s pharmaceutical market is driven by the growing healthcare demand and adoption […]
Read More →China’s pharmaceutical drug market is constantly growing and is the second-largest pharmaceutical industry in the world, after the United States. It is estimated to reach $161.8 billion by 2023, with an average growth rate of 5% in the coming years, taking a 30% share of the global market. The acceleration of new drug access, changing […]
Read More →The Philippines is the third-largest pharmaceutical market in ASEAN after Thailand and Indonesia. In 2019, total generic drug sales were PHP82.3 billion accounting for 63% of prescription sales and estimated to reach PHP110 Billion by 2024. The highest cost of medicines in the Philippines among ASEAN countries driving the purchase of more generic medicines than […]
Read More →Most errors and technical failures in clinical trials arise due to the improper selection of clinical trial designs. The clinical trial design selection will also have a strong impact on the cost and time associated with clinical trials. The expected outcomes shall be thoughtfully addressed while designing a clinical trial and the selection of clinical […]
Read More →Myanmar’s pharmaceutical market size was $456 million in 2017 with a percapita pharma expenditure of $8.5 and expected to reach $656 million in 2022. Myanmar’s economy is growing continuously, and the pharmaceutical industry is predicted to quickly grow into a $1.12 billion industry in the future. In Myanmar, both non-communicable diseases and communicable diseases are […]
Read More →